Global Automatic Mechanical Cardiopulmonary Resuscitation Devices Market - 2023-2030
Global automatic mechanical cardiopulmonary resuscitation devices market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Mechanical cardiopulmonary resuscitation (mCPR) devices deliver automated chest compressions to sudden cardiac arrest (SCA) sufferers and other conditions. These devices are developed to accomplish the recovery of spontaneous circulation (ROSC), reasonable such as manual CPR. Nevertheless, while manual CPR is subject to human blunder and exhaustion, mechanical CPR demands little human relations and can provide invariant high-quality CPR continuously.
Therefore, mCPR devices are increasingly being utilized in conjunction with manual CPR. EMS teams have encountered this technology specifically advantageous as the automated, high-quality chest compressions provide rescuers time to evaluate and treat further elements of the patient’s situation. Further, it delivers a secure and practical option for manual CPR in a moving ambulance.
Market Dynamics: Drivers & Restraints
High Prevalence of Cardiovascular Disorders
The high prevalence of cardiovascular disorders is estimated to boost demand for automatic mechanical cardiopulmonary resuscitation devices during the forecast period. For instance, according to the British Heart Association Report 2023, worldwide it is assessed that 1 out of 13 individuals are living with a cardiac or circulatory disorder and about 620 million individuals are living with heart and circulatory diseases all over the world, this number is growing owing to altering lifestyles, an aging, and growing inhabitants, and enhanced survival rates from heart attacks and strokes and is expected to persist to advance if these tendencies persist.
Moreover, in June 2021, according to the World Health Organization, an assessed 17.9 million individuals died from CVDs in 2020, symbolizing 32% of all multinational casualties out of these deaths, over 85% were because of heart attack and stroke. More than three-quarters of CVD deaths surface in low and middle-income nations like Bangladesh, Afghanistan etc. Among the 17 million premature casualties (under the age of 70) owing to non-communicable conditions in 2020, over 38% were because of CVDs. Furthermore, growing awareness, advancements and market developments among others are expected to contribute to the global market growth during the forecast period.
High Device Cost
The high cost of automatic mechanical cardiopulmonary resuscitation devices is expected to hamper the global market growth during the forecast period. For instance, the average cost of an automated CPR device is US$ 10,000. Other factors hampering the global market growth include the deficiency of skilled professionals and high development costs.
Segment AnalysisThe global automatic mechanical cardiopulmonary resuscitation devices market is segmented based on device type, power source, end user and region.
Battery-Driven CPR Devices Segment is Expected to Dominate Market
Owing to the increasing adoption of portable battery-powered automated CPR devices is expected to boost the battery-driven CPR devices market growth, dominating the global market during the forecast period. For instance, in November 2021, Horizon Health paramedics had a new, high-tech option to aid them in rescuing lives. Cardiac chest compressions that were earlier done manually, can currently be accomplished hands-free with the touch of a switch. The Horizon Health Foundation of East Central Illinois recently granted two automated CPR devices, known as AutoPulse. They are in expansion to the two AutoPulses properly in usage by the ambulance service.
Moreover, in March 2023, with a $121,835 federal grant to be used for the procurement of cardiopulmonary resuscitation (CPR) compression devices the East Haven Fire Department (EHFD) is hoping to rescue more additional lives thanks to the grant awarded via the Assistance to Firefighters Grant (AFG) program, which is part of the Federal Emergency Management Agency (FEMA). The $122,000 grant intends to supply the department with compression devices to be part of each of its unit’s apparatuses that could eliminate hindrances to manually-performed CPR for those suffering from cardiac arrests and save more lives.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the growing cases of cardiovascular diseases, increasing efforts to raise awareness and market developments boosted the North America market growth thereby holding the majority of global market share. For instance, according to the Centers for Disease Control and Prevention, approximately 695,000 individuals in the U.S. died because of heart disorders in 2021 making up for 1 out of every 5 deaths.
Moreover, in May 2023, the American Heart Association executed the 49th Emergency Medical Services (EMS) Week, which delivered awareness to the cardiovascular patients regarding the CPR devices techniques. Furthermore, in April 2023, Defibtech, a U.S. manufacturer of life-saving medical tools, introduced the next evolution of their automated CPR device, the ARM XR. The ARM XR is planned for usage by emergency medical specialists to treat patients who are in cardiac arrest.
COVID-19 Impact AnalysisCOVID-19 has positively impacted the global automated mechanical CPR devices market as during the pandemic there was an increased need to deliver CPR to patients and a deficiency of professionals which in turn increased the demand for automated mechanical CPR devices. Moreover, increased demand and guideline constraints led to the development of advanced devices requiring minimal human interaction averting the risk of infection spread.
For instance, in March 2021, NHS Tayside-a Health Board and InnoScot Health, a healthcare corporation, united to design and create the device SARUS-CPR hood that was positioned to revolutionize the resuscitation approach for first responders. SARUS-CPR hood was adopted into clinical practice by NHS Tayside following its development in reaction to the COVID-19 pandemic.
Key Developments
• In February 2022, CPR Therapeutics Inc., a medical device company obtained a U.S. patent for another element of technology that underlies its multimodal cardiopulmonary resuscitation (CPR) system: “Incorporation of the Electrodes for Defibrillation into the Patient-Facing Components of automated Cardiopulmonary Resuscitation Systems”.
• In September 2022, CPR Therapeutics Inc., a medical device company acquired a US$1.6M National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) Direct-To-Phase II Small Business Innovation Research Award for its project “A Multimodal Integrated System for Improved Cardiopulmonary Resuscitation.”.
Competitive LandscapeThe major global players in the market include ZOLL Medical Corporation, Michigan Instruments, Stryker, CPR Medical Devices, Inc., Asahi Kasei Corporation, Defibtech LLC, Yantai Wanli Medical Equipment Co., Ltd., Schiller Healthcare, Ambulanc (Shenzhen) Tech.Co., Ltd. and Sunlife Science among others.
Why Purchase the Report?• To visualize the global automatic mechanical cardiopulmonary resuscitation devices market segmentation based on device type, power source, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of automatic mechanical cardiopulmonary resuscitation devices market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global automatic mechanical cardiopulmonary resuscitation devices market report would provide approximately 61 tables, 59 figures and 186 pages.
Target Audience 2023• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies